BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 37121919)

  • 21. Iron overload induced osteocytes apoptosis and led to bone loss in Hepcidin
    Ma J; Wang A; Zhang H; Liu B; Geng Y; Xu Y; Zuo G; Jia P
    Bone; 2022 Nov; 164():116511. PubMed ID: 35933095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo.
    Wei G; Liang T; Wei C; Nong X; Lu Q; Zhao J
    J Cell Biochem; 2019 Apr; 120(4):5367-5376. PubMed ID: 30317692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Recombinant Protein EphB4-Fc Changes the Ti Particle-Mediated Imbalance of OPG/RANKL via EphrinB2/EphB4 Signaling Pathway and Inhibits the Release of Proinflammatory Factors In Vivo.
    Ge YW; Feng K; Liu XL; Chen HF; Sun ZY; Wang CF; Liu ZQ; Wang HW; Zhang JW; Yu DG; Mao YQ
    Oxid Med Cell Longev; 2020; 2020():1404915. PubMed ID: 32587656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-377 inhibits wear particle-induced osteolysis via targeting RANKL.
    Li W; Wang X; Chang L; Wang F
    Cell Biol Int; 2019 Jun; 43(6):658-668. PubMed ID: 30958621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhoifolin ameliorates titanium particle-stimulated osteolysis and attenuates osteoclastogenesis via RANKL-induced NF-κB and MAPK pathways.
    Liao S; Song F; Feng W; Ding X; Yao J; Song H; Liu Y; Ma S; Wang Z; Lin X; Xu J; Zhao J; Liu Q
    J Cell Physiol; 2019 Aug; 234(10):17600-17611. PubMed ID: 30854667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevention of titanium-particle-induced osteolysis by OA-14 through the suppression of the p38 signaling pathway and inhibition of osteoclastogenesis.
    Tian B; Jiang T; Shao Z; Zhai Z; Li H; Fan Q; Liu X; Ouyang Z; Tang T; Jiang Q; Zheng M; Dai K; Qin A; Yu Y; Zhu Z
    Biomaterials; 2014 Oct; 35(32):8937-50. PubMed ID: 25086794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piperlongumine Inhibits Titanium Particles-Induced Osteolysis, Osteoclast Formation, and RANKL-Induced Signaling Pathways.
    Liu X; Diao L; Zhang Y; Yang X; Zhou J; Mao Y; Shi X; Zhao F; Liu M
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway.
    Wijenayaka AR; Kogawa M; Lim HP; Bonewald LF; Findlay DM; Atkins GJ
    PLoS One; 2011; 6(10):e25900. PubMed ID: 21991382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of protein phosphatase 2A attenuates titanium-particle induced suppression of bone formation.
    Wang L; Bai J; Wang Q; Ge G; Lin J; Xu N; Xu C; Xu Y; Wang Y; Geng D
    Int J Biol Macromol; 2020 Jan; 142():142-151. PubMed ID: 31521663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifampin suppresses osteoclastogenesis and titanium particle-induced osteolysis via modulating RANKL signaling pathways.
    Zhu L; Kang H; Guo CA; Fan WS; Wang YM; Deng LF; Yan ZQ
    Biochem Biophys Res Commun; 2017 Feb; 484(1):64-70. PubMed ID: 28108285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway.
    Ouyang Z; Zhai Z; Li H; Liu X; Qu X; Li X; Fan Q; Tang T; Qin A; Dai K
    Biochem Pharmacol; 2014 Aug; 90(3):276-87. PubMed ID: 24950468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Sirtuin 3 prevents titanium particle-induced bone resorption and osteoclastsogenesis via suppressing ERK and JNK signaling.
    Li N; Li X; Zheng K; Bai J; Zhang W; Sun H; Ge G; Wang W; Wang Z; Gu Y; Xue Y; Xu Y; Geng D; Zhou J
    Int J Biol Sci; 2021; 17(5):1382-1394. PubMed ID: 33867853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin protects bone mass in ultra-high-molecular-weight polyethylene particle-induced osteolysis by regulating osteocyte secretion.
    Yan Z; Zhu S; Tian X; Ye Z; Zhai D; Zhu Z; Wei D; Zhu Q; Lu Z; Cao X
    J Bone Miner Metab; 2019 May; 37(3):399-410. PubMed ID: 30032440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro.
    Wu C; Wang W; Tian B; Liu X; Qu X; Zhai Z; Li H; Liu F; Fan Q; Tang T; Qin A; Zhu Z
    Biochem Pharmacol; 2015 Jan; 93(1):59-71. PubMed ID: 25449599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jatrorrhizine Hydrochloride Suppresses RANKL-Induced Osteoclastogenesis and Protects against Wear Particle-Induced Osteolysis.
    Li H; Wang J; Sun Q; Chen G; Sun S; Ma X; Qiu H; Liu X; Xu L; Liu M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of osteogenic activity by regulation of WNT and BMP signaling during titanium particle induced osteolysis.
    Nam JS; Sharma AR; Jagga S; Lee DH; Sharma G; Nguyen LT; Lee YH; Chang JD; Chakraborty C; Lee SS
    J Biomed Mater Res A; 2017 Mar; 105(3):912-926. PubMed ID: 28076890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of XCL1/Lymphotactin Ameliorates Severity of Periprosthetic Osteolysis Triggered by Polyethylene-Particles.
    Tian Y; Terkawi MA; Onodera T; Alhasan H; Matsumae G; Takahashi D; Hamasaki M; Ebata T; Aly MK; Kida H; Shimizu T; Uetsuki K; Kadoya K; Iwasaki N
    Front Immunol; 2020; 11():1720. PubMed ID: 32849609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
    Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
    J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of titanium-particle-induced inflammatory osteolysis after local administration of dopamine and suppression of osteoclastogenesis via D2-like receptor signaling pathway.
    Yang H; Xu Y; Zhu M; Gu Y; Zhang W; Shao H; Wang Y; Ping Z; Hu X; Wang L; Geng D
    Biomaterials; 2016 Feb; 80():1-10. PubMed ID: 26695376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.